[1]Yu M, Zhan J, Zhang H. HOX family transcription factors: Related signaling pathways and post-translational modifications in cancer[J]. Cell Signal,2020,66:109469.
[2]Contarelli S, Fedele V, Melisi D. HOX genes family and cancer: a novel role for homeobox B9 in the resistance to anti-angiogenic therapies[J]. Cancers (Basel),2020,12(11):3299.
[3]Mcginnis W, Levine MS, Hafen E, et al. A conserved DNA sequence in homoeotic genes of the Drosophila Antennapedia and bithorax complexes[J]. Nature,1984,308(5958):428-433.
[4]Horan GS, Ramírez-Solis R, Featherstone MS, et al. Compound mutants for the paralogous hoxa-4, hoxb-4, and hoxd-4 genes show more complete homeotic transformations and a dose-dependent increase in the number of vertebrae transformed[J]. Genes Dev,1995,9(13):1667-1677.
[5]Mcintyre DC, Rakshit S, Yallowitz AR, et al. Hox patterning of the vertebrate rib cage[J]. Development,2007,134(16):2981-2989.
[6]Garcia-Gasca A, Spyropoulos DD. Differential mammary morphogenesis along the anteroposterior axis in Hoxc6 gene targeted mice[J]. Dev Dyn,2000,219(2):261-276.
[7]van den Akker E, Fromental-Ramain C, de Graaff W, et al. Axial skeletal patterning in mice lacking all paralogous group 8 Hox genes[J]. Development,2001,128(10):1911-1921.
[8]Chen F, Greer J, Capecchi MR. Analysis of Hoxa7/Hoxb7 mutants suggests periodicity in the generation of the different sets of vertebrae[J]. Mech Dev,1998,77(1):49-57.
[9]Mallo M. Reassessing the role of hox genes during vertebrate development and evolution[J]. Trends Genet,2018,34(3):209-217.
[10]Wellik DM, Capecchi MR. Hox10 and Hox11 genes are required to globally pattern the mammalian skeleton[J]. Science,2003,301(5631):363-367.
[11]Carapu?o M, Nóvoa A, Bobola N, et al. Hox genes specify vertebral types in the presomitic mesoderm[J]. Genes Dev,2005,19(18):2116-2121.
[12]Wei XG, Bi KW, Li B. Phenotypic Plasticity conferred by the metastatic microenvironment of the brain strengthens the intracranial tumorigenicity of lung tumor cells[J]. Front Oncol,2021,11:637911.
[13]Bai L, Ge P, Zhang Y, et al. Homeobox B9 promotes the progression of hepatocellular carcinoma via TGF-β1/Smad and ERK1/2 signaling pathways[J]. Biomed Res Int,2022,2022:1080315.
[14]Zhang G, Fan E, Yue G, et al. Five genes as a novel signature for predicting the prognosis of patients with laryngeal cancer[J]. J Cell Biochem,2020,121(8-9):3804-3813.
[15]Yang X, Cheng Y, Li X, et al. A novel transcription factor-based prognostic signature in endometrial cancer: establishment and validation[J]. Onco Targets Ther,2021,14:2579-2598.
[16]Jones FS, Prediger EA, Bittner DA, et al. Cell adhesion molecules as targets for Hox genes: neural cell adhesion molecule promoter activity is modulated by cotransfection with Hox-2.5 and -2.4[J]. Proc Natl Acad Sci USA,1992,89(6):2086-2090.
[17]Zappavigna V, Renucci A, Izpisúa-Belmonte JC, et al. HOX4 genes encode transcription factors with potential auto- and cross-regulatory capacities[J]. EMBO J,1991,10(13):4177-4187.
[18]Nagel S, Burek C, Venturini L, et al. Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1[J]. Blood,2007,109(7):3015-3023.
[19]Lin J, Zhang D, Fan Y, et al. Regulation of cancer stem cell self-renewal by HOXB9 antagonizes endoplasmic reticulum stress-induced melanoma cell apoptosis via the miR-765-FOXA2 Axis[J]. J Invest Dermatol,2018,138(7):1609-1619.
[20]Xu H, Wu S, Shen X, et al. Silencing of HOXB9 suppresses cellular proliferation, angiogenesis, migration and invasion of prostate cancer cells[J]. J Biosci,2020,45:40.
[21]Wan J, Liu H, Feng Q, et al. HOXB9 promotes endometrial cancer progression by targeting E2F3[J]. Cell Death Dis,2018,9(5):509.
[22]Francis JC, Gardiner JR, Renaud Y, et al. HOX genes promote cell proliferation and are potential therapeutic targets in adrenocortical tumours[J]. Br J Cancer,2021,124(4):805-816.
[23]Zheng H, Li C, Li Z, et al. HOXB9 enhances the ability of lung cancer cells to penetrate the blood-brain barrier[J]. Aging (Albany NY),2020,13(4):4999-5019.
[24]Hayashida T, Takahashi F, Chiba N, et al. HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis[J]. Proc Natl Acad Sci USA,2010,107(3):1100-1105.
[25]Zhang L, Wu Q, He C, et al. HOXB9 inhibits proliferation in gastric carcinoma cells via suppression of phosphorylated-Akt and NF-κB-dependent Snail expression[J]. Dig Liver Dis,2019,51(1):157-165.
[26]Zhan J, Niu M, Wang P, et al. Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients[J]. Br J Cancer,2014,111(5):883-893.
[27]Zhan J, Song J, Wang P, et al. Kindlin-2 induced by TGF-β signaling promotes pancreatic ductal adenocarcinoma progression through downregulation of transcriptional factor HOXB9[J]. Cancer Lett,2015,361(1):75-85.
[28]Yao Y, Liu C, Wang B, et al. HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis[J]. Cancer Lett,2022,533:215595.
[29]Nguyen DX, Chiang AC, Zhang XH, et al. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis[J]. Cell,2009,138(1):51-62.
[30]Yuan R, Wang K, Hu J, et al. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation[J]. Cancer Res,2014,74(18):5287-5300.
[31]Xiong H, Xiao H, Luo C, et al. GRP78 activates the Wnt/HOXB9 pathway to promote invasion and metastasis of hepatocellular carcinoma by chaperoning LRP6[J]. Exp Cell Res,2019,383(1):111493.
[32]Ansari KI, Shrestha B, Hussain I, et al. Histone methylases MLL1 and MLL3 coordinate with estrogen receptors in estrogen-mediated HOXB9 expression[J]. Biochemistry,2011,50(17):3517-3527.
[33]Schmidt V, Sieckmann T, Kirschner KM, et al. WT1 regulates HOXB9 gene expression in a bidirectional way[J]. Biochim Biophys Acta Gene Regul Mech,2021,1864(11-12):194764.
[34]Drabsch Y, Ten DP. TGF-β signalling and its role in cancer progression and metastasis[J]. Cancer Metastasis Rev,2012,31(3-4):553-568.
[35]Sha L, Dong L, Lv L, et al. HOXB9 promotes epithelial-to-mesenchymal transition via transforming growth factor-β1 pathway in hepatocellular carcinoma cells[J]. Clin Exp Med,2015,15(1):55-64.
[36]Xue M, Zhu FY, Chen L, et al. HoxB9 promotes the migration and invasion via TGF-β1/Smad2/Slug signaling pathway in oral squamous cell carcinoma[J]. Am J Transl Res,2017,9(3):1151-1161.
[37]Suh DH, Park WH, Kim M, et al. HOXB9 overexpression confers chemoresistance to ovarian cancer cells by inducing ERCC-1, MRP-2, and XIAP[J]. Int J Mol Sci,2023,24(2):1249.
[38]Guo Z, Li N, Jiang Y, et al. HOXB9 a miR-122-5p regulated gene, suppressed the anticancer effects of brassaol by upregulating SCD1 expression in melanoma[J]. Biomed Pharmacother,2023,162:114650.
[39]Wan J, Xu W, Zhan J, et al. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6[J]. Nucleic Acids Res,2016,44(22):10662-10675.
[40]Song J, Wang T, Xu W, et al. HOXB9 acetylation at K27 is responsible for its suppression of colon cancer progression[J]. Cancer Lett,2018,426:63-72.
[41]Sun X, Song J, Zhang J, et al. Acetylated HOXB9 at lysine 27 is of differential diagnostic value in patients with pancreatic ductal adenocarcinoma[J]. Front Med,2020,14(1):91-100.
[42]Wang T, Guo H, Li Q, et al. The AMPK-HOXB9-KRAS axis regulates lung adenocarcinoma growth in response to cellular energy alterations[J]. Cell Rep,2022,40(8):111210.
[43]Xia YC, Zha JH, Sang YH, et al. AMPK activation by ASP4132 inhibits non-small cell lung cancer cell growth[J]. Cell Death Dis,2021,12(4):365.
[44]Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression[J]. Nat Rev Cancer,2009,9(8):563-575.
[45]Gao Y, P?ivinen P, Tripathi S, et al. Inactivation of AMPK leads to attenuation of antigen presentation and immune evasion in lung adenocarcinoma[J]. Clin Cancer Res,2022,28(1):227-237.
[46]Cai Z, Li CF, Han F, et al. Phosphorylation of PDHA by AMPK drives TCA cycle to promote cancer metastasis[J]. Mol Cell,2020,80(2):263-278.
[47]Wu SY, Rupaimoole R, Shen F, et al. A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer[J]. Nat Commun,2016,7:11169.
[48]Michalak EM, Burr ML, Bannister AJ, et al. The roles of DNA, RNA and histone methylation in ageing and cancer[J]. Nat Rev Mol Cell Biol,2019,20(10):573-589.
[49]Fang Y, Xu X, Ding J, et al. Histone crotonylation promotes mesoendodermal commitment of human embryonic stem cells[J]. Cell Stem Cell,2021,28(4):748-763.
[50]Yu J, Chai P, Xie M, et al. Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma[J]. Genome Biol,2021,22(1):85.
|